( NASDAQ-NMS:RIGL )

News from rigel pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 26, 2016, 07:30 ET Rigel Announces Conference Call and Webcast to Report First Quarter 2016 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its first quarter 2016 financial results after market...


Apr 12, 2016, 07:30 ET Rigel Announces Presentations at Upcoming American Association of Cancer Research (AACR) Conference

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will present three scientific posters at the American Association of Cancer...


Apr 01, 2016, 07:30 ET Rigel Completes Enrollment of FIT Phase 3 Program for Fostamatinib in ITP

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced it has completed enrollment for both studies in the FIT Phase 3 clinical...


Mar 08, 2016, 16:05 ET Rigel Announces Fourth Quarter and Year End 2015 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the fourth quarter and year ended December 31,...


Mar 08, 2016, 16:03 ET Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer

 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the appointment of Anne-Marie Duliege, M.D., M.S. to the role of chief medical...


Mar 01, 2016, 07:30 ET Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2015 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its fourth quarter and year end 2015 financial results...


Feb 29, 2016, 07:30 ET Rigel to Present at Cowen and Company 36th Annual Health Care Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Ryan Maynard, the company's chief financial officer, is scheduled to present a...


Feb 25, 2016, 07:30 ET Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia

 Rigel Pharmaceuticals Inc. (Nasdaq: RIGL) today announced that it has initiated a Phase 2 clinical trial to evaluate fostamatinib, its oral...


Jan 28, 2016, 07:30 ET Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP (FIT)

 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) today announced that the first of two Phase 3 clinical studies of fostamatinib in immune...


Jan 07, 2016, 07:30 ET Rigel Reviews Recent Progress and Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will...


Nov 03, 2015, 16:05 ET Rigel Announces Third Quarter 2015 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the third quarter and nine months ended September 30,...


Oct 27, 2015, 07:30 ET Rigel Announces Conference Call and Webcast to Report Third Quarter 2015 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its third quarter 2015 financial results after market...


Sep 09, 2015, 08:30 ET Rigel and Aclaris Therapeutics International Sign License Agreement for JAK Inhibitors to Treat Skin Disorders

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Aclaris Therapeutics International Limited (ATIL), a wholly owned subsidiary of...


Sep 08, 2015, 07:30 ET Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to...


Aug 04, 2015, 16:05 ET Rigel Announces Second Quarter 2015 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the second quarter and six months ended June 30,...


Jul 28, 2015, 07:30 ET Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its second quarter 2015 financial results after market...


Jun 30, 2015, 07:30 ET Rigel Welcomes Keith A. Katkin to Board of Directors

 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Keith A. Katkin, president and chief executive officer of Avanir...


May 28, 2015, 07:30 ET Rigel to Present at Jefferies 2015 Global Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled...


May 07, 2015, 16:05 ET Rigel Announces First Quarter 2015 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2015. For the first...


Apr 30, 2015, 07:30 ET Rigel Announces Conference Call and Webcast to Report First Quarter 2015 Financial Results and Pipeline Update

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its first quarter 2015 financial results after market...


Mar 03, 2015, 07:30 ET Rigel Announces Fourth Quarter and Year End 2014 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the fourth quarter and year ended...


Feb 23, 2015, 08:03 ET Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications

 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that they have entered into a...


Jan 08, 2015, 07:30 ET Rigel to Present at the 33rd Annual J.P. Morgan Healthcare Conference

 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will...


Nov 24, 2014, 07:30 ET Rigel Announces Executive Management Changes

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced James M. Gower is retiring from the board of directors and from his positions as...


Nov 04, 2014, 07:30 ET Rigel Announces Third Quarter 2014 Financial Results

 Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the third quarter and nine months ended September 30,...